- Headquarters
- Rio de Janeiro, Brazil · Latin America
- Value chain
- Medicines & vaccines(Products); also Contract manufacturing
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1976
- Ownership
- State-owned
- Website
- bio.fiocruz.br
- Relevance
- Low at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
In 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Manufacture · listed #40 of 50
Federal vaccine producer that localised AstraZeneca COVID-19 vaccine production with technology transfer, is a WHO-prequalified yellow fever vaccine supplier, and is a WHO mRNA hub partner.
Relevance: Brazilian federal vaccine producer
Biotechnology & Health Technologies · Manufacture · listed #47 of 50
Fiocruz's immunobiologicals institute, Latin America's largest vaccine producer and a WHO-prequalified yellow fever vaccine supplier, also part of the mRNA hub network.
Relevance: Latin America’s largest vaccine producer